Understanding NIPT and Sex Chromosome Aneuploidy

What is Sex Chromosome Aneuploidy?

Sex chromosome aneuploidy (SCA) refers to conditions where there are too many or too few sex chromosomes (X or Y) in a baby’s cells. Normally, females have two X chromosomes (XX) and males have one X and one Y (XY). Changes in the number of sex chromosomes can lead to conditions with varying effects on development, fertility, learning, and physical features.

How is SCA Detected?

Some non-invasive prenatal tests (NIPT) include optional screening for sex chromosome aneuploidies. This is done using a sample of the mother’s blood to analyse placental DNA fragments. While NIPT is highly accurate for common conditions like Down syndrome, the accuracy for detecting SCA is lower.

Common Sex Chromosome Aneuploidies

Should I Screen for SCA?

Many people with SCA live healthy lives and may not be diagnosed until adulthood — or not at all.

It’s important to understand that a ‘high risk’ result from NIPT for a sex chromosome condition often causes significant anxiety, but frequently turns out to be a false alarm. This is especially true when ultrasound scans are completely normal.

What are the Limitations of NIPT for SCA?

• These conditions are often mild or silent, and do not always require medical intervention.

• Positive Predictive Value (PPV) is low — false positives are common.

• Mosaicism and confined placental differences can affect results.

• Follow-up invasive tests may be offered to confirm the result — which carry a small risk.

What Happens If a Sex Chromosome Aneuploidy is Suspected?

If NIPT suggests a possible SCA:
1. You will be offered counselling to explain the result and its uncertainty.
2. Diagnostic testing (CVS or amniocentesis) may be offered.
3. A review of the baby’s scan will help determine if any features support the finding.

Summary: What You Should Know

Final Advice

Before choosing to screen for sex chromosome conditions, consider whether knowing this information will help your decision-making. If there is no family history and the scans are normal, many parents choose not to screen for SCAs, especially due to the high false positive rate and uncertainty involved.

As with all prenatal screening, making an informed decision is the most important step.

Bryan Beattie Lead Consultant in Fetal Medicine

Dr Robert Bryan Beattie MB BCh BAO MD FRCOG Dr Beattie qualified in 1983 from Queen’s University Belfast and is sub-specialty trained in Fetal and Maternal Medicine. He also holds the RCOG/RCR Joint Diploma in Obstetric Ultrasound. He was a founder member of the British Maternal and Fetal Medicine Society and is an internationally recognised pregnancy expert who is regularly called upon to speak at conferences and events. Dr Beattie is the founding Chairman and Trustee of the Innermost Academy, a registered charity dedicated to improving education in pregnancy care.

See Full Bio